Krka DD
Company Profile
Business description
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.
Contact
Smarjeska Cesta 6
Novo Mesto8501
SVNT: +386 73312111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
13,006
Stocks News & Analysis
stocks
3 Warren Buffett stocks to avoid today
stocks
Should you invest in small caps?
stocks
Strong second half anticipated for ASX mining play
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,079.20 | 17.70 | 0.20% |
CAC 40 | 7,870.68 | 75.26 | 0.97% |
DAX 40 | 23,739.47 | 204.64 | 0.87% |
Dow JONES (US) | 46,247.29 | 299.97 | 0.65% |
FTSE 100 | 9,284.83 | 70.85 | 0.77% |
HKSE | 26,128.20 | 356.48 | -1.35% |
NASDAQ | 22,484.07 | 99.37 | 0.44% |
Nikkei 225 | 45,354.99 | 399.94 | -0.87% |
NZX 50 Index | 13,111.73 | 42.06 | -0.32% |
S&P 500 | 6,643.70 | 38.98 | 0.59% |
S&P/ASX 200 | 8,787.70 | 13.20 | 0.15% |
SSE Composite Index | 3,828.11 | 25.20 | -0.65% |